➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Dow
Boehringer Ingelheim
McKinsey
Moodys

Last Updated: June 14, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR IMIPRAMINE PAMOATE

« Back to Dashboard

All Clinical Trials for imipramine pamoate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01107353 Bioequivalency Study of Imipramine Pamoate 75 mg Capsules Under Fasted Conditions Completed Roxane Laboratories N/A 2008-08-01 The objective of this study was to prove the bioequivalence of Imipramine Pamoate 75 mg Capsules under fasting conditions
NCT01389908 A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder Unknown status Shalvata Mental Health Center N/A 2011-06-01 The purpose of this study is to assess the long-term efficacy of Olanzapine Pamoate (OP) Depot in patients diagnosed with schizophrenia or schizoaffective disorder.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for imipramine pamoate

Condition Name

Condition Name for imipramine pamoate
Intervention Trials
Schizophrenia 1
Schizoaffective Disorders 1
Depression 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for imipramine pamoate
Intervention Trials
Schizophrenia 1
Psychotic Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for imipramine pamoate

Trials by Country

Trials by Country for imipramine pamoate
Location Trials
Israel 1
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for imipramine pamoate
Location Trials
Texas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for imipramine pamoate

Clinical Trial Phase

Clinical Trial Phase for imipramine pamoate
Clinical Trial Phase Trials
N/A 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for imipramine pamoate
Clinical Trial Phase Trials
Completed 1
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for imipramine pamoate

Sponsor Name

Sponsor Name for imipramine pamoate
Sponsor Trials
Shalvata Mental Health Center 1
Roxane Laboratories 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for imipramine pamoate
Sponsor Trials
Other 1
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Medtronic
Moodys
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.